已收盘 12-19 16:00:00 美东时间
-1.290
-2.38%
今日重点评级关注:富国银行:维持Milestone Pharmaceuticals"超配"评级,目标价从4美元升至8美元;富国银行:维持Kyverna Therapeutics"超配"评级,目标价从31美元升至33美元
12-17 10:46
Mizuho analyst Yaron Kinar initiates coverage on Ryan Specialty Hldgs (NYSE:RYAN) with a Neutral rating and announces Price Target of $61.
12-16 21:21
今日重点评级关注:RBC Capital:上调Neumora Therapeutics评级至"跑赢大市",目标价从4美元升至7美元;HC Wainwright & Co.:维持ProMIS Neurosciences"买入"评级,目标价从4美元升至18美元
12-02 09:50
TD Cowen analyst Andrew Kilgerman maintains Ryan Specialty Hldgs (NYSE:RYAN) with a Buy and lowers the price target from $89 to $76.
11-27 00:21
今日重点评级关注:Ascendiant Capital:维持Aclarion"买入"评级,目标价从22美元升至23美元;HC Wainwright & Co.:维持Cullinan Therapeutics"买入"评级,目标价从24美元升至26美元
11-21 15:50
今日重点评级关注:HC Wainwright & Co.:维持Oncolytics Biotech"买入"评级,目标价从5美元升至10美元;HC Wainwright & Co.:维持Barinthus Biotherapeutics"买入"评级,目标价从3美元升至4美元
11-18 15:28
Morgan Stanley analyst Bob Huang maintains Ryan Specialty Hldgs (NYSE:RYAN) with a Overweight and raises the price target from $65 to $67.
11-18 00:38
今日重点评级关注:花旗:维持Caribou Biosciences"买入"评级,目标价从5美元升至8美元;HC Wainwright & Co.:上调MoonLake Immunotherapeutics - Class A Ordinary Shares评级至"买入",目标价30美元
11-04 10:31
亚马逊涨13.52%;Ryan Specialty Group Holdings涨11.50%;Rocket Companies涨9.79%
10-31 06:13
Ryan Specialty Group Holdings将于2025年10月30日收盘后发布第三季度财报,分析师预期每股收益0.47美元,营收7.345亿美元,该财报将展示公司盈利和成本控制情况。
10-31 05:02